v3.26.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenues [Abstract]    
Revenue $ 9,461 $ 8,303
Cost of Revenue [Abstract]    
Cost of revenue 7,470 4,926
Gross profit 1,991 3,377
Research and development 9,951 5,167
Selling, general and administrative 26,320 5,784
Grant income (705) (624)
Loss from operations (33,575) (6,950)
Other income (expense):    
Interest income 3,202 356
Other, net 110 609
Total other income, net 3,312 965
Loss before income taxes (30,263) (5,985)
Income tax expense (benefit) 0 0
Net loss (30,263) (5,985)
Other comprehensive (loss) income:    
Unrealized loss on available-for-sale securities (882) 0
Foreign currency translation adjustment (99) 416
Total other comprehensive (loss) income (981) 416
Comprehensive loss $ (31,244) $ (5,569)
Basic weighted average shares outstanding 118,162,332 14,737,927
Diluted weighted average shares outstanding 118,162,332 14,737,927
Basic net loss per share $ (0.26) $ (0.41)
Diluted net loss per share $ (0.26) $ (0.41)
Product [Member]    
Revenues [Abstract]    
Revenue $ 3,150 $ 6,400
Cost of Revenue [Abstract]    
Cost of revenue 2,830 4,201
Service [Member]    
Revenues [Abstract]    
Revenue 6,311 1,903
Cost of Revenue [Abstract]    
Cost of revenue $ 4,640 $ 725